The leading event for biologics de-risking, immunoassay validation
and predicting immunogenicity in novel, highly complex molecules

Thank you for your interest in our recent 14th Annual Immunogenicity for Biotherapeutics conference! This year's conference was a great success and featured:

• Three FDA keynote speakers - An in-depth insight from FDA regulators, featuring the release of draft guidelines for biosimilar development
• Immunogenicity University - Back by popular demand, this intensive full-day summit dives into the fundamentals of immunogenicity assessment, statistical analysis and assay design – beneficial for experts at all levels of their career
• Increased Networking Opportunities - You'll have 8+ hours of networking opportunity, including a Wine and Cheese Reception where scientists can link-up with lab technicians, research providers and regulatory consultants

We are hard at work on next year's event, so make sure to sign up for event updates to receive up-to-date information.  If you are interested in speaking opportunities, please contact Allison Rigels Nilsen, Sr. Marketing Manager
To discuss sponsorship and exhibition options, please contact Andrew Sinetar, Sales Manager